Skip to main content

Table 2 SIR of ESKD in Japan compared with the total incidence of ESKD in Australia

From: Age- and gender-specific incidence rates of renal replacement therapy in Japan: an international comparison

Age group (years) Males Females
Incidence (95 % CI)a Expected cases SIR (95 % CI) Incidence (95 % CI)a Expected cases SIR (95 % CI)
0–4 0.8 (0.5–1.1) 114 0.38 (0.27–0.51) 0.3 (0.2–0.6) 41 0.91 (0.64–1.24)
5–9 0.8 (0.5–1.1) 121 0.22 (0.14–0.32) 0.6 (0.4–1.0) 86 0.21 (0.12–0.33)
10–14 0.5 (0.3–0.8) 77 0.53 (0.38–0.72) 0.8 (0.5–1.1) 117 0.33 (0.23–0.45)
15–19 1.6 (1.3–2.1) 268 0.48 (0.40–0.57) 1.3 (1.0–1.7) 207 0.39 (0.31–0.49)
20–24 2.7 (2.2–3.3) 506 0.70 (0.63–0.78) 1.8 (1.4–2.3) 319 0.56 (0.49–0.65)
25–29 4.0 (3.4–4.7) 834 0.82 (0.76–0.88) 3.0 (2.5–3.6) 602 0.67 (0.61–0.74)
30–34 4.8 (4.1–5.6) 1152 1.20 (1.14–1.27) 4.0 (3.4–4.7) 933 0.78 (0.72–0.84)
35–39 7.4 (6.5–8.3) 1635 1.33 (1.28–1.39) 5.0 (4.3–5.7) 1080 0.97 (0.91–1.03)
40–44 10.4 (9.4–11.5) 2065 1.47 (1.42–1.52) 6.8 (6.0–7.7) 1327 1.09 (1.04–1.15)
45–49 13.7 (12.5–15.0) 2644 1.79 (1.74–1.84) 8.7 (7.9–9.8) 1666 1.34 (1.29–1.40)
50–54 18.5 (17.0–20.1) 4078 2.05 (2.00–2.09) 10.8 (9.7–12.0) 2393 1.66 (1.60–1.71)
55–59 23.6 (21.9–25.5) 5839 2.22 (2.18–2.26) 16.3 (14.8–17.8) 4122 1.37 (1.33–1.41)
60–64 32.1 (29.8–34.7) 6538 2.14 (2.10–2.18) 21.2 (19.4–23.3) 4567 1.45 (1.41–1.48)
65–69 49.8 (46.4–53.4) 8895 1.80 (1.77–1.83) 33.7 (31.1–36.6) 6616 1.24 (1.22–1.27)
70–74 80.6 (75.8–85.8) 12,225 1.45 (1.43–4.70) 50.1 (46.6–53.9) 8982 1.04 (1.02–1.06)
75–79 127.5 (120.6–134.9) 14,272 1.07 (1.05–1.09) 75.8 (71.1–80.8) 11,345 0.87 (0.85–0.89)
80–84 216.1 (204.7–228.1) 13,356 0.68 (0.67–0.70) 117.5 (110.8–124.7) 12,872 0.59 (0.58–0.60)
≥85 447.3 (524.7–570.0) 18,168 0.25 (0.24–0.26) 318.7 (305.3–332.8) 33,654 0.14 (0.14–0.15)
Total 26.1 (22.5–30.0) 92,784 1.19 (1.18–1.20) 17.0 (14.9–19.2) 90,930 0.68 (0.68–0.69)
  1. Reproduced from [3]
  2. CI confidence interval, ESKD end-stage kidney disease, SIR standardised incidence ratio
  3. aPer 100,000 population
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us